"Prognosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations.
| Descriptor ID |
D011379
|
| MeSH Number(s) |
E01.789
|
| Concept/Terms |
Prognostic Factors- Prognostic Factors
- Factor, Prognostic
- Factors, Prognostic
- Prognostic Factor
|
Below are MeSH descriptors whose meaning is more general than "Prognosis".
- Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
- Diagnosis [E01]
- Prognosis [E01.789]
Below are MeSH descriptors whose meaning is more specific than "Prognosis".
This graph shows the total number of publications written about "Prognosis" by people in this website by year, and whether "Prognosis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 4 | 4 |
| 1998 | 0 | 3 | 3 |
| 1999 | 0 | 2 | 2 |
| 2000 | 0 | 9 | 9 |
| 2001 | 0 | 3 | 3 |
| 2002 | 0 | 5 | 5 |
| 2003 | 0 | 5 | 5 |
| 2004 | 0 | 9 | 9 |
| 2005 | 0 | 8 | 8 |
| 2006 | 0 | 11 | 11 |
| 2007 | 0 | 8 | 8 |
| 2008 | 0 | 8 | 8 |
| 2009 | 0 | 12 | 12 |
| 2010 | 0 | 9 | 9 |
| 2011 | 0 | 5 | 5 |
| 2012 | 0 | 12 | 12 |
| 2013 | 0 | 10 | 10 |
| 2014 | 1 | 11 | 12 |
| 2015 | 0 | 18 | 18 |
| 2016 | 0 | 18 | 18 |
| 2017 | 0 | 15 | 15 |
| 2018 | 0 | 18 | 18 |
| 2019 | 0 | 18 | 18 |
| 2020 | 0 | 13 | 13 |
| 2021 | 0 | 14 | 14 |
| 2022 | 0 | 2 | 2 |
| 2023 | 0 | 4 | 4 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Prognosis" by people in Profiles.
-
A prospective multi-cohort study identifies and validates a 5-gene peripheral blood signature predictive of immunotherapy response in non-small cell lung cancer. Mol Cancer. 2024 Nov 06; 23(1):247.
-
Association between neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, and survival in undifferentiated pleomorphic sarcoma (NLR, PLR, and overall survival in UPS). Surg Oncol. 2023 Aug; 49:101949.
-
Impact of change of ischemic burden on the outcomes of ESRD patients awaiting kidney transplantation. J Nucl Cardiol. 2023 10; 30(5):1897-1903.
-
Interstitial Lung Disease: A Focused Review for the Emergency Clinician. J Emerg Med. 2023 Feb; 64(2):156-166.
-
IgA Nephropathy with Crescents: A Single-Center Experience. Am J Nephrol. 2022; 53(11-12):786-793.
-
Study protocol for the Innovative Support for Patients with SARS-COV-2 Infections Registry (INSPIRE): A longitudinal study of the medium and long-term sequelae of SARS-CoV-2 infection. PLoS One. 2022; 17(3):e0264260.
-
The role of IGF-pathway biomarkers in determining risks, screening, and prognosis in lung cancer. Oncotarget. 2022; 13:393-407.
-
Autologous and allogeneic hematopoietic cell transplantation for diffuse large B-cell lymphoma-type Richter syndrome. Blood Adv. 2021 09 28; 5(18):3528-3539.
-
Prognostic Indicators of Survival in Sinonasal Diffuse Large B-Cell Lymphoma: A National Cancer Database Analysis. Laryngoscope. 2022 08; 132(8):1515-1522.
-
Advances in Treatment of Progressive Multifocal Leukoencephalopathy. Ann Neurol. 2021 12; 90(6):865-873.